Nigerian scientist based in Singapore, Dr Jonathan Obaje, has developed a therapy for degenerative diseases. According to a 2017 report filed by ThisDay.

Dr Obaje said the therapy ointment which is based on Urah transdermal technology is patented in the United States, Japan and Singapore. Obaje said the ointment is one of the top-selling which has fetched him many awards for its successes.

According to him, the ointment was awarded by Frosters in the US as the most innovative product for 2016. Corroborating Obaje’s claims, the Head, Corporate Affairs, Neimeth Pharmaceuticals Plc, Okay Nwaka, said the ointment is a new innovative therapy for the management of degenerative diseases such as arthritis, rheumatism, and osteoporosis. The drug is non-greasy, odourless, and is delivered seamlessly across skin layers within minutes of the applications with no placebo hot or cooling sensation.

Obaje is the current vice president of Nigerians in the Diaspora Organisation (NIDO) Singapore Chapter. UPDATE: DSS release activist Chido Onumah He is the founder and inventor of most of Urah technologies such as the Proprietary Obalin®Transdermal drug delivery System and the Biosurfactant process technology.

He holds technology patents in the US, Japan and Singapore, and has many research publications and has worked in various research positions in universities and institutes in Nigeria, England, Malaysia and Singapore. He has received a number of international academic awards, among which are the American Oil Chemists’ Society Honoured Student Award (2000) and the Lever Brothers Scholarship Award for Outstanding Graduate Student Research in Surfactants and Detergents (1999). Dr Obaje is a Chartered Scientist & Chartered Chemist (UK) and a professional member of the Royal Society of Chemistry.

Source:Legit

Email:elora.akpotosevbe@yahoo.com